Rivaroxaban-Mepha vascular 2.5 mg Filmtabletten - 100 Swissmedic Key 68440003 Registration Holder Mepha Pharma AG Name Rivaroxaban-Mepha vascular 2.5 mg Filmtabletten Date of registration 06.04.2022 Original/Generic Generic Introduction of Sequence 06.04.2022 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 05.04.2027 Index Therapeuticus (BSV) 06.03.40. Show package size 100 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 47.91 Limitation Yes Limitation text
Deductible 10 % Consumer price 68.50 Feedback FB Daily cost GTIN 7680684400032 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 2.5 mg, natrii laurilsulfas, lactosum monohydricum 184.7 mg, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), pro compresso obducto corresp. natrium max. 1.19 mg. Packungsbestandteile Active Agent Dose Rivaroxabanum 2.5 mg
BAG: Active Agent Dose Rivaroxabanum 2.5 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum E 171 color. E 172 color. Hypromellosum Lactose Monohydrate 184.7 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 05.05.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
